Uncoupling protein-1 (UCP1) is uniquely expressed in brown adipose tissue (BAT) and of major importance for the tissues thermogenic capacity. This study was undertaken to detect variants in the UCP1 gene by single strand conformational polymorphism (SSCP) analysis and subsequent sequencing, and determine their potential association with obesity. Four variants predicting for amino acid substitutions were detected, of which Arg40Trp (exon 1) and Lys257Arg (exon 5) were rare mutations. In contrast, the allele frequency of a polymorphism in exon 2 predicting for an Ala64Thr substitution was 8.2% in a cohort of 293 obese children and adolescents compared to 4.1% in 134 lean individuals, while the allele frequency of a Met229Leu variant (exon 5) was not markedly different between the obese (10.4%) and lean (12.0%) study groups. Although one of the identi®ed polymorphisms tends to have a higher frequency in obese than in lean subjects, variants of the UCP1 gene do not seem to contribute signi®cantly to the development of early-onset obesity in the German population.
Introduction
Uncoupling proteins (UCPs) are proton transport molecules whose unique capacity to uncouple oxidative metabolism from ATP synthesis results in the dissipation of energy through the release of heat. 1 The recently cloned genes encoding for UCP2 and UCP3 are expressed in numerous tissues. 2 ± 5 In contrast, the originally identi®ed UCP, now referred to as UCP1, is exclusively present in brown adipocytes. 1 Brown adipose tissue (BAT) plays an important role for energy homeostasis in rodents. The tissue is highly specialized for stimulated energy expenditure with a rich vascular supply, dense sympathetic innervation and numerous mitochondria. The phenotype of transgenic mice with BAT de®ciency supports the hypothesis that BAT activity could be a protective mechanism against obesity, as markedly diminished functional BAT mass and reduced energy expenditure in these animals lead to excessive weight gain, insulin and leptin resistance, dyslipidamia and hyperphagia. 6 ± 8 Although BAT plays a quantitatively limited role in humans, UCP1 mRNA can be detected in numerous adipose depots. 9 ± 11 When stimulated by the sympathetic nervous system, even small quantities of BAT could signi®cantly in¯uence energy homeostasis. Consequently, dysfunctional thermogenesis due to genetic defects could contribute to energy imbalance and the development of obesity. This study was undertaken to identify possible mutations in the coding sequence of the UCP1 gene and assess their prevalence in obese, compared to lean, subjects.
A cohort of extremely obese children and adolescents was ascertained at the Children's Hospital, Hochried and the Obesity Treatment Center, Insula, which specialize in the inpatient treatment of extremely obese young individuals. Of the obese subjects 97% had a body mass index (BMI) above the 95 th percentile, 61% exceeded the 100 th BMI percentile, as determined in a large and representative epidemiological sample of the German population. 12 For the purpose of this paper, we refrained from including information on age of onset of obesity, because recall errors are most likely. The second study cohort of underweight students was ascertained at the University of Marburg. They were characterized by the criteria of a BMI below the 13 th percentile, absence of somatic disorders and consumption of`10 cigarettes per day. The present sample of underweight probands represents an extension of a study group previously described 13 and both cohorts have been characterized in detail elsewhere. 14 Mean AE standard deviation age in the obese and the lean study groups were 13.7AE 2.3 y and 25.4AE 4.0 y, respectively. The obese study group comprised 53% females, while 46% of the lean individuals were female. Genetic studies were approved by the ethics committees of SSCP screening sequencing of PCR fragments with altered migration patterns resulted in the identi®cation of four missense variants that lead to amino acid substitutions (Table 1) . Allele frequency of a G?A polymorphism in exon 2 predicting for an Ala64Thr amino acid substitution was higher in the cohort of obese children and adolescents compared to the lean group (nominal P 0.029), but after Bonferroni correction for multiple testing, the difference in allele frequency between the two cohorts failed to reach statistical signi®cance (corrected P 0.058). 45 of 46 obese and 10 of 11 lean carriers of Ala64Thr were also carriers of the Met229Leu variant (nominal P 0.482). However, Ala64Thr and Met229Leu introduce the respective amino acid found in the rat UCP1 into the similar position of the human UCP1, which makes a negative effect on the thermogenic function of UCP1 rather unlikely.
While the expression of the UCP1 gene in various human fat depots has been unequivocally demonstrated, 9 ± 11 the assessment of BAT's contribution to energy balance is much more dif®cult. Due to the tissue's high thermogenic capacity, even a few grams could signi®cantly in¯uence energy expenditure in humans. In contrast to transgenic mice with BAT de®ciency, 6 ± 8 mice with a targeted disruption of the UCP1 gene are not obese. 16 This phenotypical discrepancy could result from the fact that BAT is the only tissue that expresses all three known UCPs and that UCP1 de®cient mice have a ®ve-fold increased UCP2 in BAT, but in no other tissue. However, the normal body weight of UCP1 de®cient mice does not exclude defects in the human UCP1 gene to contribute to the pathogenesis of obesity. According to the concept of susceptibility genes, a defect in UCP1 would only be expected to represent a subtle risk factor with a higher predisposition towards the 17 and in the b 3 -adrenergic receptor, through which thermogenesis in BAT is activated by the sympathetic nervous system (Trp64Arg), 18 have been shown to have additive effects since individuals with both variants have a signi®cantly increased risk to gain weight. 19 It remains to be determined whether a possible additive effect can also be observed between these polymorphisms and amino acid variants in UCP1 or another UCP. It is tempting to speculate that a subset of obese patients carries multiple defects in the UCPs and other related genes. These subjects could not only have an increased risk to develop obesity, but might also respond less well to treatment with b 3 -adrenergic agonists and other thermogenic agents. In conclusion, we have identi®ed four variants predicting for amino acid substitutions in the human UCP1 gene, one of which tends to have a higher frequency in obese compared to lean subjects.
